Barclays (LON:BARC) analyst Lauren Lieberman maintained a Buy rating on Keurig Dr Pepper (NASDAQ:KDP) on Thursday, setting a price target of $41, which is approximately 13.60% above the present share price of $36.09.
Lieberman expects Keurig Dr Pepper to post earnings per share (EPS) of $0.32 for the fourth quarter of 2021.
The current consensus among 6 TipRanks analysts is for a Strong Buy rating of shares in Keurig Dr Pepper, with an average price target of $40.17.
The analysts price targets range from a high of $42 to a low of $36.
In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $3.14 billion and a net profit of $734 million. The company's market cap is $51.16 billion.
According to TipRanks.com, Barclays analyst Lauren Lieberman is currently ranked with 2 stars on a 0-5 stars ranking scale, with an average return of 0.8% and a 50.40% success rate.
Massachusetts-based Keurig Dr Pepper, Inc. operates as a non-alcoholic beverage company in the US and internationally. It operates through four segments: Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages.